2-Nitropropane

CASRN 79-46-9

  • IRIS Summary (PDF) (10 pp, 110 K)
  • Status: 2-Nitropropane is not being reassessed by IRIS at this time.

Health Hazard Assessments for Effects Other than Cancer


Reference Dose for Oral Exposure (RfD) (PDF) (10 pp, 110 K)
Not assessed under the IRIS Program.

Reference Concentration for Inhalation Exposure (RfC) (PDF) (10 pp, 110 K) last updated: 03/01/1991

RfC (mg/m3) System Basis PoD Composite UF Confidence
2 x 10-2 Hepatic Liver focal vacuolization and nodules LOAEL (HEC): 1.6 x 101
mg/m3
1000 Low

Cancer Assessment


Weight of Evidence for Cancer (PDF) (10 pp, 110 K)
Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (10 pp, 110 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (10 pp, 110 K)

Not assessed under the IRIS Program.

You will need Adobe Reader to view some of the files on this page. See EPA’s PDF page to learn more.